Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

NCT ID: NCT05686278

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

368 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-29

Study Completion Date

2033-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As part of the current clinical remediation work under the new Medical Device Regulation (MDR), limited data have been identified to support the hemiarthroplasty indication for some of Corin femoral stems. Therefore, this PMCF study has been implemented to collect safety and performance data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Hip Hemiarthroplasty Osteoarthritis, Hip Avascular Necrosis of Hip Femoral Neck Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)

Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices

Bipolar i and cemented stem (Océane+ or Meije)

Intervention Type DEVICE

Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bipolar i and cemented stem (Océane+ or Meije)

Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Both genders.
2. Adult subjects.
3. Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.
4. The subject is willing to comply with the required follow-up visits as per protocol.
5. The subject has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC.

Exclusion Criteria

1. Subjects with active infection or sepsis or osteomyelitis.
2. Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis.
3. Subject with marked bone loss or bone absorption.
4. Subject with metabolic disorders which may impair bone formation or bone quality.
5. Subjects under guardianship.
6. Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Corin

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe HULET, MD, PhD

Role: STUDY_CHAIR

University Hospital, Caen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ch Amboise

Amboise, , France

Site Status NOT_YET_RECRUITING

Polyclinique Henin Beaumont

Hénin-Beaumont, , France

Site Status NOT_YET_RECRUITING

Hopital Saint Joseph

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vanessa GRIMAUD

Role: CONTACT

0667267075

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vincent NOEL, MD

Role: primary

0247233333

Romain GALMICHE, MD

Role: primary

0321133000

Peter UPEX, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSP2021-05-FR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hip Prospective Study
NCT05956236 RECRUITING
Cephalic Femoral Heads Follow Up
NCT06873568 NOT_YET_RECRUITING
The Medacta Quadra-P Anteverted Study
NCT05460715 ACTIVE_NOT_RECRUITING
CoCrMo LOCK Bipolar Femoral Heads FU
NCT06885359 NOT_YET_RECRUITING